CJC-1295 + Ipamorelin
| Catalog # | CP-5044 |
| Purity | ≥ 99% |
| Molecular formula | Per Certificate of Analysis |
| Molecular weight | Per COA |
| Available formats | Combination |
| Documentation | HPLC purity · ESI-MS identity · Certificate of Analysis |
| Designation | For Research Use Only |
In plain English
This is a research pairing of CJC-1295 and Ipamorelin, two peptides scientists use to study how different hormone-signaling receptor systems coordinate in cells. It is intended for laboratory research only, not for human use.
Technical description
CJC-1295 and Ipamorelin are synthetic peptides referenced in scientific literature involving neuroendocrine signaling and peptide-receptor interactions. CJC (a modified GHRH analog) has been examined for its interaction with GHRH receptors and pulsatile signaling patterns, while Ipamorelin, a selective ghrelin receptor (GHSR-1a) agonist, has been studied for its receptor-binding properties and downstream intracellular signaling; combined in research environments, they allow investigators to explore complementary receptor pathways. CliniPeptide supplies the pairing as lyophilized powders (>99% purity) for research use only.
